Expert Opinion on Drug Discovery
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University. Less
Key Metrics
View Chart Journal Specifications
- PublisherTAYLOR & FRANCIS LTD
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year2006
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 46% |
| 4-6 | 47% |
| 7-9 | 6% |
| >9 | 1% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Expert Opinion on Drug Discovery been publishing? 
The Expert Opinion on Drug Discovery has been publishing since 2006 till date.
How frequently is the Expert Opinion on Drug Discovery published?
Expert Opinion on Drug Discovery is published Bi-monthly.
Who is the publisher of Expert Opinion on Drug Discovery?
The publisher of Expert Opinion on Drug Discovery is TAYLOR & FRANCIS LTD.
Where can I find a journal's aims and scope of Expert Opinion on Drug Discovery?
For the Expert Opinion on Drug Discovery's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Expert Opinion on Drug Discovery on editage?
For the Expert Opinion on Drug Discovery metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Expert Opinion on Drug Discovery?
The eISSN number is 1746-045X and pISSN number is 1746-0441 for Expert Opinion on Drug Discovery.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Assay, Drug discovery, Central nervous system, Rheumatoid arthritis, Cancer therapy, CRISPR, Chagas disease, Fluorine, Machine learning, Artificial intelligence, Drug development, Tumor microenvironment, Adalimumab, Thioredoxin reductase, Pharmaceutical industry, Clinical efficacy, Cystic fibrosis, Drug design, Leptin, Histone deacetylase.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.